| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |